28 March 2023: Aker BioMarine ASA today publishes its Annual Report for 2022,
which includes the annual accounts, the report on ESG (Environmental, Social and
Governance) and the auditor's report for 2022.

The report is attached and is also available at www.akerbiomarine.com.

Aker BioMarine ASA has also published its annual financial statements in
European
Single Electronic Format (ESEF), available as an attachment to this release.


For further information, please contact 
Katrine Klaveness, CFO
Mobile: +47 991 58 915
Email: Katrine.Klaveness@akerbiomarine.com

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act.

About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for pharma, consumer health and
wellness as well as animal nutrition. The company has a strong position in its
industry and is the world's leading supplier of krill, the natural, powerful and
health promoting source of nutrients from the pristine waters of Antarctica.
Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is
available at www.akerbiomarine.com.